Stocktoria
BELITE BIO, INC BLTE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-04-29
Chart by TradingView
3/9
Piotroski F — financial health
82.91
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$84.2M | -$40.0M | -$31.7M | -$12.8M | -$9.8M |
| Net income | -$77.6M | -$36.1M | -$31.6M | -$12.6M | -$9.7M |
| Operating cash flow | -$37.0M | -$29.2M | -$29.8M | -$11.5M | -$7.5M |
| Free cash flow | -$37.1M | -$29.4M | -$29.9M | -$11.9M | -$7.5M |
| Total assets | $780.6M | $152.1M | $94.6M | $44.3M | $18.3M |
| Total liabilities | $10.1M | $6.3M | $4.2M | $2.8M | $1.6M |
| Shareholders' equity | $770.5M | $145.8M | $90.4M | $41.5M | -$15.1M |
| Ratios | |||||
| Return on assets | -9.9% | -23.8% | -33.4% | -28.6% | -52.7% |
| Return on equity | -10.1% | -24.8% | -35.0% | -30.5% | 64.0% |
| Current ratio | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 52,000 | $8.3M |
| Duquesne Family Office LLC | 106,100 | $16,917 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 82.91 (safe)
- Working capital / assets 0.621
- Retained earnings / assets -0.237
- EBIT / assets -0.108
- Equity / liabilities 76.513
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001889109 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.